Zacks Investment Research on MSN3d
Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag
Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of ...
pharmaphorum2d
FDA fast-tracks Sanofi's experimental chlamydia vaccine
Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...
En Pareja on MSN5d
SIGNS a Guy Might Have Chlamydia and How to Get Rid of It
Living a healthy life means knowing the symptoms of chlamydia and taking the necessary precautions under a doctor's guidance.
MPR3d
Chlamydia Vaccine Candidate Gets Fast Track Status
The Food and Drug Administration (FDA) has granted Fast Track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.
PharmExec2d
FDA Grants Fast Track Designation to Sanofi’s mRNA Chlamydia Vaccine
As part of the Fast Track designation, Sanofi is set to launch a Phase I/II trial to evaluate the immunogenicity and safety of its novel mRNA vaccine in preventing chlamydia.
Medical Dialogues3d
Sanofi gets USFDA fast track designation for Chlamydia vaccine candidate
Paris: Sanofi has received the US Food and Drug Administration (USFDA) fast-track designation for its mRNA vaccine candidate ...
Press Release: Chlamydia vaccine candidate granted fast track designation by the US FDA
Chlamydia vaccine candidate granted fast track designation by the US FDAChlamydia infection can contribute to pelvic inflammatory diseases in ...
Yahoo Finance3d
Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag
Caused by the bacterium Chlamydia trachomatis, chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications. The vaccine candidate ...
European Medical Journal1d
Sanofi’s chlamydia vaccine fast-tracked by FDA
This decision underscores the need for a preventative measure against the chlamydia, which affects millions worldwide.
Pharmabiz2d
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection
US FDA grants fast track designation to Sanofi’s mRNA vaccine candidate for prevention of chlamydia infection: Paris Friday, March 28, 2025, 12:00 Hrs [IST] The US Food and Drug ...
Contract Pharma3d
Sanofi’s Chlamydia Vaccine Candidate Granted Fast Track Designation by FDA
The FDA has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection.